NovelStem International Corp. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that NovelStem International Corp. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue (Net Sales)
Net sales revenue — gross revenue less returns, allowances, and discounts. Used by many manufacturers and retailers as the primary top-line figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $616.3K | Apr 1, 2013 |
| FY2011 | Dec 31, 2011 | $3.77M | Apr 16, 2012 |
| FY2011 | Dec 31, 2010 | $4.00M | Apr 16, 2012 |
| FY2011 | Dec 31, 2009 | $4.52M | Apr 16, 2012 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.38M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | ($3.23M) | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | ($4.19M) | Apr 7, 2025 |
| FY2023 | Dec 31, 2022 | ($765.7K) | Apr 1, 2024 |
| FY2022 | Sep 30, 2022 | ($682.1K) | Mar 31, 2023 |
| FY2022 | Jun 30, 2022 | ($386.8K) | Mar 31, 2023 |
| FY2022 | Mar 31, 2022 | ($169.3K) | Mar 31, 2023 |
| FY2022 | Dec 31, 2021 | ($1.35M) | Mar 31, 2023 |
| FY2012 | Dec 31, 2012 | $10.41M | Apr 1, 2013 |
| FY2012 | Dec 31, 2011 | ($6.86M) | Apr 1, 2013 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($238.8K) | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | ($927.9K) | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | ($3.53M) | Apr 7, 2025 |
| FY2023 | Dec 31, 2022 | ($422.4K) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($495.5K) | Mar 31, 2023 |
| FY2012 | Dec 31, 2012 | ($5.70M) | Apr 1, 2013 |
| FY2012 | Dec 31, 2011 | ($5.81M) | Apr 1, 2013 |
| FY2011 | Dec 31, 2010 | ($7.66M) | Apr 16, 2012 |
| FY2011 | Dec 31, 2009 | ($8.01M) | Apr 16, 2012 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $2.85M | Apr 1, 2013 |
| FY2011 | Dec 31, 2011 | $3.37M | Apr 16, 2012 |
| FY2011 | Dec 31, 2010 | $3.68M | Apr 16, 2012 |
| FY2011 | Dec 31, 2009 | $4.34M | Apr 16, 2012 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($167.6K) | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | ($272.0K) | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | ($348.3K) | Apr 7, 2025 |
| FY2023 | Dec 31, 2022 | ($182.3K) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($180.9K) | Mar 31, 2023 |
| FY2012 | Dec 31, 2012 | ($3.92M) | Apr 1, 2013 |
| FY2012 | Dec 31, 2011 | ($2.60M) | Apr 1, 2013 |
| FY2011 | Dec 31, 2010 | $3.93M | Apr 16, 2012 |
| FY2011 | Dec 31, 2009 | $3.96M | Apr 16, 2012 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $84.0K | Apr 1, 2013 |
| FY2011 | Dec 31, 2011 | $97.4K | Apr 16, 2012 |
| FY2011 | Dec 31, 2010 | $141.7K | Apr 16, 2012 |
| FY2011 | Dec 31, 2009 | $101.6K | Apr 16, 2012 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $15.8K | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $160.1K | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $2.25M | Apr 7, 2025 |
| FY2023 | Dec 31, 2022 | $2.29M | Apr 1, 2024 |
| FY2022 | Sep 30, 2022 | $2.23M | Mar 31, 2023 |
| FY2022 | Jun 30, 2022 | $2.35M | Mar 31, 2023 |
| FY2022 | Dec 31, 2021 | $2.61M | Mar 31, 2023 |
| FY2012 | Dec 31, 2012 | $26.62M | Apr 1, 2013 |
| FY2012 | Dec 31, 2011 | $18.22M | Apr 1, 2013 |
| FY2011 | Dec 31, 2010 | $47.32M | Apr 16, 2012 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $2.16M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | $5.30M | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | $4.21M | Apr 7, 2025 |
| FY2023 | Dec 31, 2022 | $353.3K | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | $193.2K | Mar 31, 2023 |
| FY2012 | Dec 31, 2012 | $1.66M | Apr 1, 2013 |
| FY2012 | Dec 31, 2011 | $3.65M | Apr 1, 2013 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($2.14M) | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | ($5.14M) | Mar 26, 2026 |
| FY2025 | Dec 31, 2023 | ($1.95M) | Mar 26, 2026 |
| FY2024 | Dec 31, 2022 | $1.93M | Apr 7, 2025 |
| FY2022 | Sep 30, 2022 | $1.93M | Mar 31, 2023 |
| FY2022 | Jun 30, 2022 | $2.15M | Mar 31, 2023 |
| FY2023 | Dec 31, 2021 | $2.42M | Apr 1, 2024 |
| FY2022 | Dec 31, 2020 | $3.49M | Mar 31, 2023 |
| FY2012 | Dec 31, 2012 | $24.96M | Apr 1, 2013 |
| FY2012 | Dec 31, 2011 | $14.58M | Apr 1, 2013 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $6.20M | Apr 1, 2013 |
| FY2011 | Dec 31, 2011 | $9.80M | Apr 16, 2012 |
| FY2011 | Dec 31, 2010 | $14.60M | Apr 16, 2012 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($293.98M) | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | ($296.36M) | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | ($293.13M) | Apr 7, 2025 |
| FY2023 | Dec 31, 2022 | ($288.94M) | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | ($288.17M) | Mar 31, 2023 |
| FY2025 | Sep 30, 2018 | ($7.30M) | Mar 26, 2026 |
| FY2012 | Dec 31, 2012 | ($268.86M) | Apr 1, 2013 |
| FY2012 | Dec 31, 2011 | ($279.27M) | Apr 1, 2013 |
| FY2011 | Dec 31, 2010 | ($272.41M) | Apr 16, 2012 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $6.1K | Apr 7, 2025 |
| FY2024 | Dec 31, 2023 | $53.1K | Apr 7, 2025 |
| FY2022 | Dec 31, 2022 | $6.3K | Mar 31, 2023 |
| FY2022 | Dec 31, 2021 | $8.7K | Mar 31, 2023 |
| FY2012 | Dec 31, 2012 | $11.38M | Apr 1, 2013 |
| FY2012 | Dec 31, 2011 | $3.68M | Apr 1, 2013 |
| FY2012 | Dec 31, 2010 | $29.37M | Apr 1, 2013 |
| FY2011 | Dec 31, 2009 | $8.37M | Apr 16, 2012 |
| FY2011 | Dec 31, 2008 | $5.40M | Apr 16, 2012 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Apr 7, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 0 | Mar 31, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | 0 | Apr 7, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Apr 1, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 46.88M | Mar 26, 2026 |
| FY2025 | Dec 31, 2024 | 46.88M | Mar 26, 2026 |
| FY2024 | Dec 31, 2023 | 46.88M | Apr 7, 2025 |
| FY2023 | Dec 31, 2022 | 46.88M | Apr 1, 2024 |
| FY2022 | Dec 31, 2021 | 46.88M | Mar 31, 2023 |
| FY2012 | Dec 31, 2012 | 23.16M | Apr 1, 2013 |
| FY2012 | Dec 31, 2011 | 23.18M | Apr 1, 2013 |
| FY2012 | Feb 25, 2011 | 23.18M | Apr 1, 2013 |
| FY2011 | Dec 31, 2010 | 31.18M | Apr 16, 2012 |